Ralcorp (RAH +4.4%) rejects ConAgra's (CAG +1.7%) $4.9B buyout offer and adopts a poison pill...


Ralcorp (RAH +4.4%) rejects ConAgra's (CAG +1.7%) $4.9B buyout offer and adopts a poison pill defense to prevent outside control of the company. "We are confident that Ralcorp has a strategic plan and a proven management team that will continue to generate significant shareholder value in the future," Ralcorp Chairman William Stiritz says.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs